Monoamine oxidase inhibitor-induced speech blockage.
Speech blockage has been identified by recent case reports as a side effect of tricyclics in the treatment of depression. The first report of speech blockage associated with a monoamine oxidase inhibitor is presented and the possible mechanisms are discussed. All reports, including this one, associate this phenomenon with clinical improvement.